Should You Sell IDEXX Laboratories (IDXX)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 2,662,855 | $1,100,930,771 | -1% | 4.69% |
| 2. | Alyeska Investment Group Anand Parekh | 378,318 | $156,411,794 | 0.58% | |
| 3. | Millennium Management Israel Englander | 256,228 | $105,934,904 | +65% | 0.05% |
| 4. | D E Shaw D. E. Shaw | 212,136 | $87,705,508 | +69% | 0.06% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 207,114 | $85,629,215 | +633% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | Director | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | Director | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | Director | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | Director | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | Director | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $462.53 | 9,986 | Officer | 8,176 | 2025-02-10 | Filing | |
| $465.95 | 3,000 | Director | 3,061 | 2025-02-07 | Filing | |
| $420.44 | 344 | Director | 905 | 2024-11-27 | Filing | |
| $469.37 | 500 | Director | 0 | 2024-09-06 | Filing | |
| $540.80 | 200 | Director | 161 | 2024-05-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 265,949 | $111,685,283 | 7.3% | |
| 2. | 183,195 | $76,932,622 | 0.07% | |
| 3. | 31,802 | $13,355,250 | 5.73% | |
| 4. | 24,537 | $10,304,313 | 1.02% | |
| 5. | 18,807 | $7,898,000 | 0.07% |
News See All
8 Best Pet Stocks to Buy According to Billionaires
The pet industry is expected to continue growing in the coming years, driven by changing consumer preferences and innovative trends.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.
IDEXX Laboratories (IDXX) Fell Due to Weakening of Clinical Visits by Patients
Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why IDEXX Laboratories (IDXX) Declined in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S.
Jim Cramer On 9 Stocks That Are Rallying Despite Tariff Worries
On Monday, Jim Cramer, the host of Mad Money, told viewers that they should not be too surprised by President Donald Trump's decision to impose steep tariff hikes, a move Trump had promised during his...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
Why IDXX Is Soaring Today
Pet healthcare firm Idexx (IDXX) is jumping 10% after delivering better-than-expected fourth-quarter financial results.
Jim Cramer Looked At These 7 Stocks Recently
On Mad Money, Jim Cramer recently delved into the impact of previous President Joe Biden’s policies on the stock market, raising a question that has been on the minds of many executives: Did the market...
Billionaire Hedge Funds
